Retour
Prix Yonghe Medical Group Co., Ltd. (02279.HK)
Graphique du cours de l'action 02279.HK
YONGHE MEDICAL (02279.HK)
Yonghe Medical Group Co., Ltd.
HK$2
0%
$0
Marché fermé: Feb 16, 12:00:00 HKT
Pas encore de donnéesFollow-Up Questions
Báo cáo tài chính chính của Yonghe Medical Group Co., Ltd. là gì?
Tỷ lệ tài chính chính của 02279.HK là gì?
Doanh thu của Yonghe Medical Group Co., Ltd. được phân bổ theo phân khúc hoặc khu vực địa lý như thế nào?
Yonghe Medical Group Co., Ltd. có lợi nhuận không?
Yonghe Medical Group Co., Ltd. có nợ không?
Yonghe Medical Group Co., Ltd. có bao nhiêu cổ phiếu đang lưu hành?
Statistiques clés
Clôture préc.
$1.97
Prix d'ouverture
$2
Plage de la journée
$2 - $2
Plage de 52 semaines
$0.85 - $3.56
Volume
89.5K
Volume moyen
274.1K
BPA (TTM)
-0.12
Rendement en dividend
--
Capitalisation boursière
$999.7M
Qu’est-ce que YONGHE MEDICAL ?
Yonghe Medical Group Co., Ltd. is an investment holding company, which engages in the provision of hair-related healthcare services covering hair transplant, medical hair care, routine hair restoration, and other ancillary services. The company is headquartered in Beijing, Beijing and currently employs 3,228 full-time employees. The company went IPO on 2021-12-13. The firm offers one-stop hair-related healthcare services covering hair transplant, medical hair care, routine hair restoration and other ancillary services. The firm has built a brand matrix for the full industry chain which is centered on Yonghe Medical and comprised of Yonghe Hair Transplant for professional hair transplant service, Svenson for medical hair care service, Yonghe Fa Zhi Chu for female aesthetic hair transplant service, and Harvard for medical wig products. The firm also provides medical-grade hair health management service for patients facing hair diseases in a more professional way using medical testing, diagnosis and personalized nursing treatment through Svenson Medical Hair Care Centers. The firm mainly conducts its businesses in China market.
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.